[[{“value”:”
RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD. MiRecule, winner in the biopharma track of MedCity News’s Pitch Perfect startup competition, is now pursuing a Series A round of financing.
The post How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance appeared first on MedCity News.
“}]]
